| 000 | 01043 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516080251.0 | ||
| 264 | 0 | _c20120404 | |
| 008 | 201204s 0 0 fre d | ||
| 022 | _a0035-2640 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDelarue, Richard | |
| 245 | 0 | 0 |
_a[Evaluation of chlorambucil in CLL: better late than never]. _h[electronic resource] |
| 260 |
_bLa Revue du praticien _cNov 2011 |
||
| 300 |
_aS3-4 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xtherapeutic use |
| 650 | 0 | 4 |
_aChlorambucil _xtherapeutic use |
| 650 | 0 | 4 |
_aDrug Evaluation _xmethods |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 |
_aMedical Oncology _xmethods |
| 650 | 0 | 4 |
_aProduct Surveillance, Postmarketing _xstandards |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 773 | 0 |
_tLa Revue du praticien _gvol. 61 _gno. 9 Suppl _gp. S3-4 |
|
| 999 |
_c21548732 _d21548732 |
||